Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.

Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ.

Mol Psychiatry. 2012 Mar;17(3):242-66. doi: 10.1038/mp.2011.109. Epub 2011 Sep 6. Review.

PMID:
21894153
2.

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.

Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL.

J Clin Psychiatry. 2001;62 Suppl 23:45-66. Review.

3.
4.

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.

Baptista T, Kin NM, Beaulieu S, de Baptista EA.

Pharmacopsychiatry. 2002 Nov;35(6):205-19. Review.

PMID:
12518268
5.

Pharmacogenetics of antipsychotic-induced weight gain.

Correll CU, Malhotra AK.

Psychopharmacology (Berl). 2004 Aug;174(4):477-89. Epub 2004 Jul 8. Review.

PMID:
15243737
6.

Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.

Shams TA, Müller DJ.

Curr Psychiatry Rep. 2014 Oct;16(10):473. doi: 10.1007/s11920-014-0473-9. Review.

PMID:
25138234
7.

Management of schizophrenia with obesity, metabolic, and endocrinological disorders.

Monteleone P, Martiadis V, Maj M.

Psychiatr Clin North Am. 2009 Dec;32(4):775-94. doi: 10.1016/j.psc.2009.08.003. Review.

PMID:
19944883
8.

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

Stahl SM, Mignon L, Meyer JM.

Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x. Review.

PMID:
19178394
9.

Metabolic side effects of antipsychotic medication.

Tschoner A, Engl J, Laimer M, Kaser S, Rettenbacher M, Fleischhacker WW, Patsch JR, Ebenbichler CF.

Int J Clin Pract. 2007 Aug;61(8):1356-70. Review.

PMID:
17627711
10.

Susceptibility genes for the side effect of antipsychotics on body weight and obesity.

Chagnon YC.

Curr Drug Targets. 2006 Dec;7(12):1681-95. Review.

PMID:
17168843
11.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718
12.

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.

Maayan L, Correll CU.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):517-35. doi: 10.1089/cap.2011.0015. Epub 2011 Dec 13. Review.

PMID:
22166172
13.

Metabolic syndrome and obesity among users of second generation antipsychotics: A global challenge for modern psychopharmacology.

Rojo LE, Gaspar PA, Silva H, Risco L, Arena P, Cubillos-Robles K, Jara B.

Pharmacol Res. 2015 Nov;101:74-85. doi: 10.1016/j.phrs.2015.07.022. Epub 2015 Jul 26. Review.

PMID:
26218604
14.

Weight gain and metabolic syndrome among young patients on antipsychotic medication: what do we know and where do we go?

Eapen V, John G.

Australas Psychiatry. 2011 Jun;19(3):232-5. doi: 10.3109/10398562.2010.539609. Review.

PMID:
21682621
15.

Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.

Volavka J, Citrome L.

Expert Opin Pharmacother. 2009 Aug;10(12):1917-28. doi: 10.1517/14656560903061309. Review.

PMID:
19558339
16.

Weight gain and antipsychotics: a drug safety review.

Musil R, Obermeier M, Russ P, Hamerle M.

Expert Opin Drug Saf. 2015 Jan;14(1):73-96. doi: 10.1517/14740338.2015.974549. Epub 2014 Nov 15. Review.

PMID:
25400109
17.

Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J.

Drug Saf. 2006;29(7):587-98. Review.

PMID:
16808551
18.

Genetics of antipsychotic treatment emergent weight gain in schizophrenia.

Müller DJ, Kennedy JL.

Pharmacogenomics. 2006 Sep;7(6):863-87. Review.

PMID:
16981847
19.

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.

Arranz MJ, de Leon J.

Mol Psychiatry. 2007 Aug;12(8):707-47. Epub 2007 Jun 5. Review.

PMID:
17549063
20.

Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.

Newcomer JW.

J Clin Psychiatry. 2004;65 Suppl 18:36-46. Review.

Supplemental Content

Support Center